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LYNNE S. STEINBACH
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In 1987, the National Institutes of Health formed
the Radiology Diagnostic Oncology Group (RDOG)
to perform multi-institutional comparative studies of
relevant imaging modalities in the staging of various
malignancies. One such study was recently com-
pleted: CT and MR imaging in the local staging of
primary malignant musculoskeletal neoplasms:
Report of the Radiology Diagnostic Oncology
Group. Radiology 1997; 202:237± 46.
The primary investigator is David Panicek, MD,
an associate professor of radiology at Memorial
Sloan-Kettering Cancer Center. This was a collabo-
rative effort between radiologists and pathologists
from the following medical centers: Memorial
Sloan-Kettering Cancer Center, Massachusetts
General Hospital, University of California Los
Angeles and Stanford University Hospital. The
study enrolled 367 eligible patients ranging in age
from 6 to 89 years with malignant bone or soft tissue
neoplasms. Of these, 316 patients were able to
complete the study and have their images analyzed.
Primary bone tumors were present in 183 patients
and primary soft tissue tumors in 133 patients.
This carefully conducted investigation utilized a
paired study design in which each patient under-
went imaging with computed tomography (CT) and
magnetic resonance imaging (MRI) for staging of
primary malignant musculoskeletal tumors within a
period of 4 weeks prior to surgical resection. For
each patient, CT scans were interpreted indepen-
dently by two radiologists and MR images by two
other radiologists at the enrolling institution. The
CT and MR images were then interpreted together
by two of those radiologists and subsequently reread
at the other institutions. Imaging and histopatho-
logic ® ndings were compared and were supple-
mented when needed with surgical ® ndings.
Surgeons were not blinded to diagnosis or imaging
studies prior to surgery. Receiver operating charac-
teristic curve analysis and descriptive statistical
analysis were performed.
The study concluded that CT and MR imaging
were equally accurate in the local staging of malig-
nant bone and soft tissue neoplasms. Combined
interpretation of CT and MR images did not statis-
tically signi® cantly improve accuracy. Inter-reader
variability was similar for both modalities.
The authors are to be applauded for their efforts.
Signi® cant time and energy went into preparation
and evaluation of these cases. Some of the conclu-
sions were surprising. It was of interest to discover
that the length of the intramedullary tumor and the
maximum dimension of the tumor in the soft tissues
tended to be overestimated with both CT and MRI.
As mentioned in the paper, the soft tissue dis-
crepancy may be related to changes in dimension
when measured outside the body following resec-
tion.
This study has been a subject of controversy since
its publication. Many radiologists believe that MRI
has higher soft tissue contrast and multi-planar
capability that improves and facilitates evaluation of
extent of musculoskeletal tumors. As stated by the
authors of this article: ª it is possible that other
important but less easily quanti® able information is
gleaned by the surgeon from MR images and MR
increases the surgeon’s con® dence in the pre-operat-
ive staging dataº . Most radiologists would agree
with this.
It is important to look at some of the ¯ aws of the
study. One must look at the time-frame of the study
and the equipment and methodology used. This
study was conducted between 1991 and early 1995.
The equipment was state of the art for its time:
however, newer CT and MR equipment and soft-
ware is now available producing the potential to
alter the results of the study. Patients who under-
went CT had the bene® t of additional intravenous
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contrast material, whereas those who had MRI did
not receive intravenous contrast, which is often ad-
ministered by radiologists for improved characteri-
zation and visualization of musculoskeletal tumors,
particularly to evaluate the soft tissue component.
Spin-echo MR imaging techniques were utilized.
Short tau inversion recovery (STIR) sequences, and
the newer fat-suppressed fast spin echo T2-weighted
MR sequences, which are very sensitive for tumors,
were not employed. This discrepancy in methodol-
ogy could bias the results towards CT.
Another important fact that should be mentioned
is that the study was skewed predominantly towards
evaluation of the more common bone and soft tissue
tumorsÐ osteosarcoma, chondrosarcoma, malignant
® brous histiocytoma and liposarcoma. Round cell
tumors were excluded by design because they re-
spond to pre-operative therapy and there is little
mass left to evaluate at surgery and pathology.
A relatively small number of patients (15) had
neurovascular involvement, which weakens statisti-
cal power for conclusions that MR and CT are
limited in their ability to assess neurovascular en-
casement. However, the fact that neurovascular in-
volvement occurred rarely is important information
in and of itself.
It is recommended that the decision to use of CT
or MRI be applied on an individual basis. It will
always be dif® cult to keep up with technological
advances in cross-sectional imaging: however, a fol-
low-up study that utilizes state of the art imaging is
probably needed to con® rm the conclusions of this
study.